From antibody-drug conjugates to immuno-oncology checkpoint inhibitors, China is the world’s most closely watched rising ...

In five years’ time, the mental health treatment landscape will look radically different. We need funding to keep up with ...

We generally don’t think of rare-disease advocacy as funny. But Sammy Basso, who died at 28, will be remembered for his ...

There are currently no licensed vaccines or drugs to prevent or treat Marburg, but experimental versions are heading to ...

U.S. health officials have run into obstacles in their efforts to determine whether a Missouri person infected with H5N1 bird ...

Spread of the virus is seasonal, with activity often picking up in the fall after kids go back to school. Activity usually ...

In June 2023, Trump’s campaign released a video and statement indicating that the policy could make a comeback during a ...

Steward Health Care may have collapsed, but unchecked hospital consolidation lives on, write philanthropists Laura and John ...

Ahead of the BIOSECURE Act, WuXi AppTec is in talks to sell its Philadelphia-based cell and gene therapy unit, and WuXi ...

We think it’s time to lean into messaging as an important care modality for the future. PCPs can no longer balance both ...

Next year’s Medicare Advantage market will be two things at once: remarkably stable broadly, but rife with changes under the ...

After Pfizer withdrew its sickle cell drug from the market, patients with the condition and their doctors were left ...